OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
Béla Kiss, Balázs Krámos, I. Laszlovszky
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 6
Béla Kiss, Balázs Krámos, I. Laszlovszky
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 6
Showing 6 citing articles:
Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
Healthcare (2024) Vol. 12, Iss. 3, pp. 339-339
Open Access | Times Cited: 7
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
Healthcare (2024) Vol. 12, Iss. 3, pp. 339-339
Open Access | Times Cited: 7
Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling
D. Kavindi Weerasinghe, Jason M. Hodge, Julie A. Pasco, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
D. Kavindi Weerasinghe, Jason M. Hodge, Julie A. Pasco, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Third-Generation Antipsychotics and Lurasidone in The Treatment of Substance-Induced Psychoses: A Narrative Review
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
(2024)
Open Access | Times Cited: 4
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
(2024)
Open Access | Times Cited: 4
Substance Addiction Rehabilitation Drugs
Shu Yuan, Sicong Jiang, Zhongwei Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 615-615
Open Access | Times Cited: 2
Shu Yuan, Sicong Jiang, Zhongwei Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 615-615
Open Access | Times Cited: 2
D3 Receptor-Targeted Cariprazine: Insights from Lab to Bedside
Ágota Barabássy, Z.B. Dombi, György Németh
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5682-5682
Open Access
Ágota Barabássy, Z.B. Dombi, György Németh
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5682-5682
Open Access
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder
Pornjira Pariwatcharakul, Chuthamanee Suthisisang
Journal of Clinical Psychopharmacology (2022) Vol. 43, Iss. 1, pp. 79-80
Closed Access | Times Cited: 2
Pornjira Pariwatcharakul, Chuthamanee Suthisisang
Journal of Clinical Psychopharmacology (2022) Vol. 43, Iss. 1, pp. 79-80
Closed Access | Times Cited: 2
